Dimensional structure of first episode psychosis.


Journal

Early intervention in psychiatry
ISSN: 1751-7893
Titre abrégé: Early Interv Psychiatry
Pays: Australia
ID NLM: 101320027

Informations de publication

Date de publication:
12 2019
Historique:
received: 15 03 2017
revised: 13 02 2018
accepted: 26 12 2018
pubmed: 16 1 2019
medline: 10 3 2020
entrez: 16 1 2019
Statut: ppublish

Résumé

Current diagnostic systems, DSM-5 and ICD-10, still adopt a categorical approach to classify psychotic disorders. The present study was aimed at investigating the structure of psychotic symptomatology in both affective and non-affective psychosis from a dimensional approach. Participants with a first episode psychosis (FEP) were recruited from a cluster-randomized controlled trial (GET-UP PIANO TRIAL), offered to all Community Mental Health Centres (CMHCs) located across two northern Italian regions. After clinical stabilization, patients were assessed with a comprehensive set of psychopathological measures including the Positive and Negative Syndrome Scale, the Hamilton Depression Rating Scale and the Bech-Rafaelsen Mania Rating Scale. A two-step cluster analysis was performed. Overall, 257 FEP patients (male, n = 171, 66.5%; mean age = 24.96 ± 4.56) were included in the study. The cluster analysis revealed a robust four-cluster solution: delusional-persecutory (n = 82; 31.9%), depressed (n = 95; 37%), excited (n = 26; 10.1%) and negative-disorganized (n = 54; 21%), thus suggesting a quadripartite structure with both affective and non-affective dimensions. Among non-affective dimensions, negative and disorganization symptoms constituted a unique construct apart from positive symptoms. Symptom dimensions may represent a useful tool for dissecting the indistinct and non-specific psychopathology of FEP in order to better target specific interventions.

Identifiants

pubmed: 30644165
doi: 10.1111/eip.12789
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1431-1438

Subventions

Organisme : Italian Ministry of Health
ID : H61J08000200001
Pays : International

Informations de copyright

© 2019 John Wiley & Sons Australia, Ltd.

Références

Arndt, S., Andreasen, N. C., Flaum, M., Miller, D., & Nopoulos, P. (1995). A longitudinal study of symptom dimensions in schizophrenia: Prediction and patterns of change. Archives of General Psychiatry, 52, 352-360.
Bech, P., Bolwig, T., Kramp, P., & Rafaelsen, O. J. (1979). The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatrica Scandinavica, 59, 420-430.
Bleuler, E. (1911). Dementia praecox oder die Gruppe der Schizophrenien. Wien, Austria: Franz Deuticke Editor.
Bobes, J., Ciudad, A., Álvarez, E., San, L., Polavieja, P., & Gilaberte, I. (2009). Recovery from schizophrenia: Results from a 1-year follow-up observational study of patients in symptomatic remission. Schizophrenia Research, 115, 58-66. https://doi.org/10.1016/j.schres.2009.07.003
Buchanan, R. W., & Carpenter, W. T. (1994). Domains of psychopathology: An approach to the reduction of heterogeneity in schizophrenia. The Journal of Nervous and Mental Disease, 182, 193-204.
Cattell, R. B. (1966). The scree test for the number of factors. Multivariate Behavioral Research, 1, 245-276.
Ceskova, E., Prikryl, R., & Kasparek, T. (2011). Outcome in males with first-episode schizophrenia: 7-year follow-up. The World Journal of Biological Psychiatry, 12, 66-72. https://doi.org/10.3109/15622975.2010.518625
Cocchi, A., Cerati, G., Lora, A., Meneghelli, A., Monzani, E., Percudani, M., … Preti, A. (2014). Patients with first-episode psychosis are not a homogeneous population: Implications for treatment. Clinical Practice and Epidemiology in Mental Health, 10, 1-8. https://doi.org/10.2174/1745017901410010001
Costello, A. B., & Osborne, J. W. (2005). Best practices in exploratory factor analysis: Four recommendations for getting the most from your analysis. Practical Assessment, Research and Evaluation, 10, 1-9.
Eaton, W. W., Thara, R., Federman, B., Melton, B., & Liang, K. Y. (1995). Structure and course of positive and negative symptoms in schizophrenia. Archives of General Psychiatry, 52, 127-134.
Fowler, D., Hodgekins, J., French, P., Marshall, M., Freemantle, N., McCrone, P., … Singh, S. (2018). Social recovery therapy in combination with early intervention services for enhancement of social recovery in patients with first-episode psychosis (SUPEREDEN3): A single-blind, randomised controlled trial. The Lancet Psychiatry, 5, 41-50.
Gabriel, E. (1987). Dysphoric mood in paranoid psychoses. Psychopathology, 20, 101-106.
Greenfield, P., Joshi, S., Christian, S., Lekkos, P., Gregorowicz, A., Fisher, H. L., & Johnson, S. (2018). First episode psychosis in the over 35 s: Is there a role for early intervention? Early Intervention in Psychiatry, 12, 348-354. https://doi.org/10.1111/eip.12322
Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278-296.
Heckers, S., Barch, D. M., Bustillo, J., Gaebel, W., Gur, R., Malaspina, D., … Carpenter, W. (2013). Structure of the psychotic disorders classification in DSM5. Schizophrenia Research, 150, 11-14. https://doi.org/10.1016/j.schres.2013.04.039.
Huys, Q. J. M. (2018). Advancing clinical improvements for patients using the theory-driven and data-driven branches of computational psychiatry. JAMA Psychiatry, 75, 225-226. https://doi.org/10.1001/jamapsychiatry.2017.4246
Insel, T. R. (2010). Rethinking schizophrenia. Nature, 468, 187-193. https://doi.org/10.1038/nature09552
Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., Korten, A., & Cooper, J. E. (1992). Schizophrenia: manifestations, incidence and course in different cultures: A World Health Organization Ten-Country Study. Psychological Medicine Monograph Supplement, 20, 1-97.
Johnstone, E. C., & Frith, C. D. (1996). Validation of three dimensions of schizophrenic symptoms in a large unselected sample of patients. Psychological Medicine, 26, 669-679.
Kay, S. R., Fiszbein, A., & Opfer, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276.
Kendler, K. S., Karkowski, L. M., & Walsh, D. (1998). The structure of psychosis: Latent class analysis of probands from the Roscommon Family Study. Archives of General Psychiatry, 55, 492-499.
Keshavan, M. S., Tandon, R., Boutros, N. N., & Nasrallah, H. A. (2008). Schizophrenia, “just the facts”: What we know in 2008: Part 3: Neurobiology. Schizophrenia Research, 106, 89-107. https://doi.org/10.1016/j.schres.2008.07.020
Keymer-Gausset, A., Alonso-Solís, A., Corripio, I., Sauras-Quetcuti, R. B., Pomarol-Clotet, E., Canales-Rodriguez, E. J., … Portella, M. J. (2018). Gray and white matter changes and their relation to illness trajectory in first episode psychosis. European Neuropsychopharmacology, 28, 392-400.
Kirkbride, J. B., Fearon, P., Morgan, C., Dazzan, P., Morgan, K., Tarrant, J., … Jones, P. B. (2006). Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: Findings from the 3-center AeSOP study. Archives of General Psychiatry, 63, 250-258.
Langeveld, J., Andreassen, O. A., Auestad, B., Faerden, A., Hauge, L. J., Joa, I., … Larsen, T. K. (2013). Is there an optimal factor structure of the Positive and Negative Syndrome Scale in patients with first episode psychosis? Scandinavian Journal of Psychology, 54, 160-165. https://doi.org/10.1111/sjop.12017
Liddle, P. F. (1987). The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. British Journal of Psychiatry, 151, 145-151.
Loo, R. (1979). The orthogonal rotation of factors in clinical research: A critical note. Journal of Clinical Psychology, 35, 762-765.
Maj, M. (2011). Understanding the pathophysiology of schizophrenia: Are we on the wrong or on the right track? Schizophrenia Research, 127, 20-21. https://doi.org/10.1016/j.schres.2011.01.002
Marchesi, C., Affaticati, A., Monici, A., De Panfilis, C., Ossola, P., Ottoni, R., & Tonna, M. (2015). Decrease of functioning in remitted and non-remitted patients 16 years after a first-episode schizophrenia. The Journal of Nervous and Mental Disease, 203, 406-411. https://doi.org/10.1097/NMD.0000000000000299
Marchesi, C., Affaticati, A., Monici, A., De Panfilis, C., Ossola, P., & Tonna, M. (2014). Predictors of symptomatic remission in patients with first-episode schizophrenia: A 16years follow-up study. Comprehensive Psychiatry, 55(4), 778-784. https://doi.org/10.1016/j.comppsych.2013.12.011
Maziade, M., Bouchard, S., Gingras, N., Charron, L., Cardinal, A., Roy, M. A., … Martinez, M. (1996). Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II: Post-negative distinction and childhood predictors of adult outcome. British Journal of Psychiatry, 169, 371-378.
McGorry, P. D., Bell, R. C., Dudgeon, P. L., & Jackson, H. J. (1998). The dimensional structure of first episode psychosis: An exploratory factor analysis. Psychological Medicine, 28, 935-947.
Munro, A. (1988). Delusional (paranoid) disorders: Etiologic and taxonomic considerations. II. A possible relationship between delusional and affective disorders. Canadian Journal of Psychiatry, 33, 175-178.
Peralta, V., & Cuesta, M. J. (2001). How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophrenia Research, 49, 269-285.
Peralta, V., & Cuesta, M. J. (2003). The nosology of psychotic disorders: A comparison among competing classification systems. Schizophrenia Bulletin, 29, 413.
Peralta, V., de Leon, J., & Cuesta, M. J. (1992). Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy. British Journal of Psychiatry, 161, 335-343.
Perugi, G., Medda, P., Reis, J., Rizzato, S., Mariani, M. G., & Mauri, M. (2013). Clinical subtypes of severe bipolar mixed states. Journal of Affective Disorders, 151, 1076-1082. https://doi.org/10.1016/j.jad.2013.08.037
Petruzzelli, M. G., Margari, L., Bosco, A., Craig, F., Palumbi, R., & Margari, F. (2018). Early onset first episode psychosis: Dimensional structure of symptoms, clinical subtypes and related neurodevelopmental markers. European Child & Adolescent Psychiatry, 26. https://doi.org/10.1007/s00787-017-1026-7
Pope, H. G., & Lipinski, J. F. (1978). Diagnosis in schizophrenia and manic-depressive illness: A reassessment of the specificity of 'schizophrenic' symptoms in the light of current research. Archives of General Psychiatry, 35, 811-828.
Robinson, D. G., Schooler, N. R., Correll, C. U., John, M., Kurian, B. T., Marcy, P., … Kane, J. M. (2018). Psychopharmacological treatment in the RAISE-ETP study: Outcomes of a manual and computer decision support system based intervention. American Journal of Psychiatry, 175, 169-179.
Ruggeri, M., Bonetto, C., Lasalvia, A., De Girolamo, G., Fioritti, A., Rucci, P., … Soares, J. C. (2012). A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: Study protocol for a pragmatic cluster randomized controlled trial. Trials, 13, 73. https://doi.org/10.1186/1745-6215-13-73
Ruggeri, M., Bonetto, C., Lasalvia, A., Fioritti, A., de Girolamo, G., Santonastaso, P., … Meneghelli, A. (2015). Feasibility and effectiveness of a multi-element psychosocial intervention for first-episode psychosis: Results from the cluster-randomized controlled GET UP PIANO trial in a catchment area of 10 million inhabitants. Schizophrenia Bulletin, 4, 1192-1203. https://doi.org/10.1093/schbul/sbv058
Russo, M., Levine, S. Z., Demjaha, A., Di Forti, M., Bonaccorso, S., Fearon, P., … Reichenberg, A. (2014). Association between symptom dimensions and categorical diagnoses of psychosis: A cross-sectional and longitudinal investigation. Schizophrenia Bulletin, 40, 111-119. https://doi.org/10.1093/schbul/sbt055
Schanda, H. (2000). Paranoia and dysphoria: Historical developments, current concepts. Psychopathology, 33, 204-208.
Selvendra, A., Baetens, D., Trauer, T., Petrakis, M., & Castle, D. (2014). First episode psychosis in an adult area mental health service-A closer look at early and late-onset first episode psychosis. Australasian Psychiatry, 22, 235-241. https://doi.org/10.1177/1039856214532558
Subramaniam, M., Zheng, H., Soh, P., Poon, L. Y., Vaingankar, J. A., Chong, S. A., & Verma, S. (2016). Typology of people with first-episode psychosis. Early Intervention in Psychiatry, 10, 346-354. https://doi.org/10.1111/eip.12178
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009). Schizophrenia, “just the facts” 4. Clinical features and conceptualization. Schizophrenia Research, 110, 1-23. https://doi.org/10.1016/j.schres.2009.03.005
Uren, J., Cotton, S. M., Killackey, E., Saling, M. M., & Allott, K. (2017). Cognitive clusters in first-episode psychosis: Overlap with healthy controls and relationship to concurrent and prospective symptoms and functioning. Neuropsychology, 31, 787-797.
van der Gaag, M., Hoffman, T., Remijsen, M., Hijman, R., de Haan, L., van Meijel, B., … Wiersma, D. (2006). The five-factor model of the Positive and Negative Syndrome Scale II: A ten-fold cross-validation of a revised model. Schizophrenia Research, 85, 280-287.
White, C., Stirling, J., Hopkins, R., Morris, J., Montague, L., Tantam, D., & Lewis, S. (2009). Predictors of 10-year outcome of first-episode psychosis. Psychological Medicine, 39, 1447-1456. https://doi.org/10.1017/S003329170800514X
World Health Organization. (1992). Schedules for Clinical Assessment in Neuropsychiatry. Geneva, Switzerland: World Health Organization.

Auteurs

Matteo Tonna (M)

Dipartimento di Medicina e Chirurgia, Unità di Psichiatria, Università di Parma, Parma, Italy.

Paolo Ossola (P)

Dipartimento di Medicina e Chirurgia, Unità di Psichiatria, Università di Parma, Parma, Italy.

Carlo Marchesi (C)

Dipartimento di Medicina e Chirurgia, Unità di Psichiatria, Università di Parma, Parma, Italy.

Elena Bettini (E)

Dipartimento di Medicina e Chirurgia, Unità di Psichiatria, Università di Parma, Parma, Italy.

Antonio Lasalvia (A)

UOC Psichiatria, Azienda Ospedaliera Universitaria Integrata (AOUI) Verona, Verona, Italy.

Chiara Bonetto (C)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.

Jacopo Lenzi (J)

Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.

Paola Rucci (P)

Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.

Laura Iozzino (L)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.

Massimo Cellini (M)

Department of Mental Health, Az. USL Firenze, Florence, Italy.

Carla Comacchio (C)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.

Doriana Cristofalo (D)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.

Armando D'Agostino (A)

Department of Psychiatry, University of Milano, Milan, Italy.

Giovanni de Girolamo (G)

Psychiatric Epidemiology and Evaluation Unit, IRCSS St John of God Clinical Research Centre of Brescia, Brescia, Italy.

Katia De Santi (K)

UOC Psichiatria, Azienda Ospedaliera Universitaria Integrata (AOUI) Verona, Verona, Italy.

Daniela Ghigi (D)

Department of Mental Health, Az. USL Rimini, Rimini, Italy.

Emanuela Leuci (E)

Department of Mental Health, Az. USL Parma, Parma, Italy.

Maurizio Miceli (M)

Department of Mental Health, Az. USL Firenze, Florence, Italy.

Anna Meneghelli (A)

AO Ospedale Niguarda Ca' Granda Milano, MHD Programma2000, Milan, Italy.

Francesca Pileggi (F)

Department of Mental Health, Az.USL Bologna, Bologna, Italy.

Silvio Scarone (S)

Department of Psychiatry, University of Milano, Milan, Italy.

Paolo Santonastaso (P)

Department of Neurosciences, University of Padova and Azienda Ospedaliera, Padova, Italy.

Stefano Torresani (S)

Department of Mental Health, Az. USL Bolzano, Bolzano, Italy.

Sarah Tosato (S)

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.

Angela Veronese (A)

Department of Neurosciences, University of Padova and Azienda Ospedaliera, Padova, Italy.

Angelo Fioritti (A)

Department of Mental Health, Az.USL Bologna, Bologna, Italy.

Mirella Ruggeri (M)

UOC Psichiatria, Azienda Ospedaliera Universitaria Integrata (AOUI) Verona, Verona, Italy.
Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH